lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Cardiovascular disease and erectile dysfunction - Clinical Opal

15 January 2024 - A/Prof Tim Moss

Vince is a 58-year-old male. He is a social smoker and has a family history of heart disease.

Physical examination indicates Vince is overweight and well virilised. His waist circumference is 104cm and weight is 98kg. His blood pressure is 160/94.

Clinical investigations show:

  • fasting blood glucose: 5.2 mmol/L
  • fasting lipids:
    • total cholesterol: 5.8 mmol/L
    • triglycerides: 2.3 mmol/L
    • HDL-chol: 0.9 mmol/L
    • LDL-chol: 4.4 mmol/L

Key areas of concern are the heart disease risk factors including:

  • high BP
  • smoker
  • family history of heart disease
  • waist circumference greater than 100 cm
  • hyperlipidaemia

At this stage you have excluded any further cardiovascular or endocrine conditions.

Given Vince’s age and health status, you ask Vince about his sexual function. Vince reports low libido and difficulty in maintaining an erection.

What treatments may assist Vince in managing erectile function whilst addressing lifestyle factors for cardiovascular health?

For some men with erectile problems it is important to talk about the first line of treatment, which is to alter modifiable risk factors and causes and address any impacts that current medications may be having on sexual function. Once this is addressed consider any psychosocial factors that may be contributing.

Consider prescription of a PDE5 inhibitor:

When prescribing PDE5 inhibitors (either on-demand dosing or daily dosing regimens):

  • adapt dose as necessary, according to the response and side-effects.

  • ensure patient knows that sexual stimulation is required for drug to work: the tablets alone don’t give you an erection.

  • contraindicated in patients who take long-acting nitrates, short-acting, nitrate-containing medications, or recreational nitrates (amyl nitrate).

  • exercise caution when considering PDE5 inhibitors for patients with: active coronary ischaemia, congestive heart failure and borderline low blood pressure, borderline low cardiac volume status, a complicated multi-drug antihypertensive program, or using any drug therapy that can prolong the half-life of PDE5 inhibitors.

  • investigate chest pain previously not clinically assessed or undue shortness of breath.

In this case it is safe to prescribe the PDE5 inhibitor however further consultation with the patients’ cardiologist is recommended when considering prescription.

Related Content and Further Learning


References

1.    Yafi et al., 2016. Erectile dysfunction. Nature Reviews Disease Primers. Available from:
https://www.nature.com/articles/nrdp20163

2.    Sooriyamoorthy & Leslie 2021. Erectile Dysfunction. In: StatPearls. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK562253/

A/Prof Tim Moss
A/Prof Tim Moss

Associate Professor Tim Moss BSc PhD is Health Content Manager at Healthy Male and holds an adjunct appointment in the Department of Obstetrics and Gynaecology at Monash University. He is listed among the top 2% of most influential scientists of all time in the field of obstetrics and reproductive medicine.

Tim joined Healthy Male in 2020 after 25 years of working in academia and medical research. Tim learned science communication at the Alan Alda Centre for Science Communication and the School of Journalism at Stony Brook University, and the SciComm Lab in the Department of Engineering at Massachusetts Institute of Technology. 

Get Medcast Plus

Become a member and get unlimited access to 100s of hours of premium education.

Learn more
Related News
PODCAST: Addressing disease burden, risk factors and health behaviours in Australian males aged 18-44

A/Prof Tim Moss

Men’s Health Week is June 10 -16 2024. Listen in to this podcast to learn about what is impacting the health and wellbeing of Australian men and how we can support males to adopt healthy behaviours.

35 mins READ
Reporting options for victim/survivors of sexual violence

Dr Maaike Moller

Sexual violence is both a health and public safety issue. This means that many incidents of sexual violence may result in contact with health service.

PODCAST: Engaging Australian males in healthy lifestyles

Professor Gary Wittert

Chronic disease is underpinned by lifestyle and health behaviour choices across the life course. Listen in as we discuss the impact of health behaviours on Australian males and the strategies you can adopt to better support males to improve their health and wellbeing.

30 mins READ